- Home
- MHH vs GNTA Comparison
MHH vs GNTA Comparison
Compare MHH & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- GNTA
- Stock Information
- Founded
- MHH 1986
- GNTA 2014
- Country
- MHH United States
- GNTA Italy
- Employees
- MHH N/A
- GNTA N/A
- Industry
- MHH Professional Services
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MHH Consumer Discretionary
- GNTA Health Care
- Exchange
- MHH Nasdaq
- GNTA Nasdaq
- Market Cap
- MHH 87.6M
- GNTA 81.2M
- IPO Year
- MHH N/A
- GNTA 2021
- Fundamental
- Price
- MHH $6.79
- GNTA $3.88
- Analyst Decision
- MHH
- GNTA Strong Buy
- Analyst Count
- MHH 0
- GNTA 1
- Target Price
- MHH N/A
- GNTA $25.00
- AVG Volume (30 Days)
- MHH 18.8K
- GNTA 5.4K
- Earning Date
- MHH 08-06-2025
- GNTA 01-01-0001
- Dividend Yield
- MHH N/A
- GNTA N/A
- EPS Growth
- MHH N/A
- GNTA N/A
- EPS
- MHH 0.17
- GNTA N/A
- Revenue
- MHH $200,437,000.00
- GNTA N/A
- Revenue This Year
- MHH $1.22
- GNTA N/A
- Revenue Next Year
- MHH $5.41
- GNTA N/A
- P/E Ratio
- MHH $39.53
- GNTA N/A
- Revenue Growth
- MHH 3.93
- GNTA N/A
- 52 Week Low
- MHH $6.20
- GNTA $2.79
- 52 Week High
- MHH $16.00
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- MHH 43.74
- GNTA 39.03
- Support Level
- MHH $6.39
- GNTA $3.70
- Resistance Level
- MHH $6.85
- GNTA $6.12
- Average True Range (ATR)
- MHH 0.43
- GNTA 0.43
- MACD
- MHH -0.01
- GNTA -0.07
- Stochastic Oscillator
- MHH 30.73
- GNTA 7.23
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.